NYSE:GENI charts & data provided by TradingView

Latest Insights on GENI

Molecules of U.S. Freedom
by Joseph Hargett May 30, 2019 Great Stuff
I’m sorry … I just can’t stop laughing… “Freedom gas”!  OK, breathe… This week … ahem … the Department of Energy (DOE), in all seriousness, rebranded natural gas with a more patriotic spin. In most aspects, it was your standard report on the health of the U.S. natural gas market. The government agency touted the development of […]
Great Stuff 5-24-2019 T-Mobile Pulls a Fast One; Amazon at $3,000?
by Joseph Hargett May 24, 2019 Great Stuff
The Friday Four Play No. 1: T-Mobile + Netflix On You While the Federal Communications Commission and the Department of Justice are battling it out over whether T-Mobile USA Inc. (Nasdaq: TMUS) and Sprint Corp. (NYSE: S) should be allowed to get married, the “Big T” is pulling a fast one. T-Mobile’s Netflix On Us […]
ALERT: Top Investor Reveals Safe Pot Stock Trades
by Charles Mizrahi May 16, 2019 American Investor Today, Cannabis, Investing
Whenever a new trend starts in the market, many companies rival to be the top dog. Once the craze dies down, however, only a few companies capture all of the available market share for that industry. To make money from a trend, it’s crucial to know how to pick profitable companies. Charles Mizrahi shares with you an exclusive presentation on a booming mega trend: the cannabis market. (3-minute read)
Why Choosing Stock Market Winners Makes You a Better Trader
by Charles Mizrahi April 18, 2019 American Investor Today, Investing
The best way to be a winner is to surround yourself with winners. Charles Mizrahi shares his take on this well-known motto with you, and how he applies it to his expertise when it comes to choosing stocks that are set to make huge gains.
The amount of new clinical trials is increasing exponentially. This gives constant opportunities to profit from biotech companies releasing results. Biotech Has More Opportunities Than Ever Before
by Ian Dyer September 19, 2018 Investment Opportunities
The amount of new clinical trials is increasing exponentially. This gives constant opportunities to profit from biotech companies releasing results.

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

“I started with $215,000 in Nov. 2018, It is now over 800,000. So very happy with Banyan Hill Publishing.”

- Larry K.

“At the end of August [2018], my 401K was $659,000. Now, on September 4th [2018], it’s $715,000. My account is up $56,000 in the last 5 days!”

- Warren O

“My portfolio has grown from 275k to almost 900k with only investments made with Banyan Hill.”

- David G. (Member since 2018)

Share This